Prexige Approval Status 
- FDA approved: No
- Brand name: Prexige
- Generic name: lumiracoxib
- Company: Novartis AG
- Treatment for: Osteoarthritis
Prexige (lumiracoxib) is a COX-2 inhibitor under review for the once-daily treatment of patients suffering from osteoarthritic pain. Although Prexige is currently approved in more than 50 countries, it is unlikely the painkiller will gain FDA approval.
FDA Approval Status for Prexige
| Date | Article |
|---|---|
| Sep 27, 2007 | Prexige Receives "Not Approvable" Letter in the US Despite Being One of the Most Studied COX-2 Inhibitors |
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
